KALV.D

KalVista Pharmaceuticals, Inc.

Healthcare · Biotechnology

$269.73 sample

+2.15 (+0.80%) 1D

Market cap

$1.27T

Price as of

2026-10-24

Latest filing

8-K · 2026-10-06

Alerts

8

Price$269.73 +28.75% 3M daily closessample

269.73204.50

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 19INSInsider sell: EVP, Operations
Oct 12INSInsider sell: Chief Financial Officer
Oct 06SEC8-K filed: material event
Sep 29INSInsider sell: Chief Executive Officer
Sep 22SEC10-Q filed
Sep 17SECDEF 14A filed
Sep 11INSInsider sell: Chief Executive Officer
Sep 02SECForm 144 filed

Sign up to see the real KALV.D record →

Company facts

SEC EDGAR registration

Name: KalVista Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +45sample, -100 to +100
Reporting currency: USD

Who is positioning in KALV.D

sample

Insiders: 8 insider transactions over 90 days, net selling, $629.6M
Congress: 4 members traded over 90 days
Institutions · 13F: 6 funds hold $19.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$82.0B +15.4% y/y

Q4 2024Q3 2026

Inventory$46.9B +10.5% y/y

Q4 2024Q3 2026

Accounts receivable$37.0B +11.6% y/y

Q4 2024Q3 2026

Total debt$91.8B +10.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $512.6B +14.4% 3M
Sample peer B: $459.1B -9.7% 3M
Sample peer C: $758.0B -11.9% 3M
Sample peer D: $334.1B -0.6% 3M
Sample peer E: $944.6B -3.0% 3M